Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ribociclib and Endocrine Therapy in Premenopausal ER+/HER2- Breast Cancer
NCT04753177Phase 3Unknown
- Start
- Jan 2021
- Primary completion
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ribociclib in breast cancer. Status: unknown.
02
Drugs
ribociclib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT04753177.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04753177.